Royal Bank of Canada

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24,810
Total Value
350517986000
Accession Number
0001140361-25-019231
Form Type
13F-HR
Manager Name
Royal Bank of Canada
Data Enrichment
78% identified
19,259 identified5,551 unidentified

Holdings

24,810 positions
Manager:
Search and click to pin securities to the top
Page 303 of 331
CBAK Energy Technology, Inc.
Shares:
4484
Value:
$4.0M
MAGIC SOFTWARE ENTERPRISES LTD
Shares:
300(-25.0%)
Value:
$4.0M(-20.0%)
Septerna, Inc.
Shares:
802(-42.6%)
Value:
$4.0M(-87.5%)
SolarMax Technology, Inc.
Shares:
2718(-3.4%)
Value:
$4.0M(-20.0%)
Inhibrx Biosciences, Inc.
Shares:
319(-75.9%)
Value:
$4.0M(-81.0%)
Sana Biotechnology, Inc.
Shares:
2674(-61.8%)
Value:
$4.0M(-63.6%)
MBX Biosciences, Inc.
Shares:
635(-23.8%)
Value:
$4.0M(-75.0%)
PEDEVCO CORP
Shares:
5000(+0.0%)
Value:
$4.0M(+0.0%)
BioAge Labs, Inc.
Shares:
1099(-98.5%)
Value:
$4.0M(-99.1%)
RAPT Therapeutics, Inc.
Shares:
3670
Value:
$4.0M
46654Q104
Shares:
79(+0.0%)
Value:
$4.0M(+0.0%)
MITEK SYSTEMS INC
Shares:
493(-64.3%)
Value:
$4.0M(-73.3%)
KAMADA LTD
Shares:
538
Value:
$4.0M
Sound Point Meridian Capital, Inc.
Shares:
185(-25.4%)
Value:
$4.0M(-20.0%)
TURKCELL ILETISIM HIZMETLERI A S
Shares:
562(+16.8%)
Value:
$4.0M(+0.0%)
StealthGas Inc.
Shares:
734(+155.7%)
Value:
$4.0M(+100.0%)
693149106
Shares:
329(-97.3%)
Value:
$4.0M(-98.0%)
26923N744
Shares:
100(-75.0%)
Value:
$4.0M(-80.0%)
Inozyme Pharma, Inc.
Shares:
4770(-44.4%)
Value:
$4.0M(-82.6%)
IDT CORP
Shares:
80(-92.8%)
Value:
$4.0M(-92.5%)